Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer. - Sasada S; Kondo N; Hashimoto H; Takahashi Y; Terata K; Kida K; Sagara Y; Ueno T; Anan K; Suto A; Kanbayashi C; Takahashi M; et al. (Breast cancer research and treatment, 2023)